-
Mashup Score: 0eNavvi, Mark Cuban Cost Plus Drug Company partner to empower - 2 month(s) ago
Physicians will have the ability to compare medication prices in real-time and prescribe using eNavvi’s platform.
Source: www.mobihealthnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Q&A: GoodRx on partnerships for reducing drug prices - 9 month(s) ago
Doug Hirsch, cofounder and chief mission officer at GoodRx, sat down with MobiHealthNews to discuss the discount drug company’s partnership with grocery store chain Publix.
Source: www.mobihealthnews.comCategories: General Medicine News, Future of MedicineTweet-
Q&A: @GoodRx on partnerships for reducing drug prices | #pharma #drugpricing https://t.co/OBmxNTNfP2
-
-
Mashup Score: 1Bernie Will Get CEOs to Capitol Hill; NC Will Not Get Obesity Meds to Its Beneficiaries - 11 month(s) ago
And other reasons why the next 10 days in DrugPricingLand are going to be so intense
Source: costcurve.beehiiv.comCategories: General Medicine News, Future of MedicineTweet-
.@brianreid seems to be insinuating that certified genius Tommy Tuberville (HELP committee minuority member) may not be capable of understanding complexity as it relates to pharma pricing. Wonder if he'll even bothering to show up? https://t.co/MQEPVoKCzR #pharma #drugpricing
-
-
Mashup Score: 0
After many years of tracking the pharmaceutical industry’s pricing tactics, the Institute for Clinical and Economic Review (ICER) is once again placing a spotlight on the price increases that end u | The Institute for Clinical and Economic Review (ICER)’s fifth annual report on unsupported price increases (UPI) puts Humira in the top spot of offenders.
Source: www.fiercepharma.comCategories: General Medicine News, General HCPsTweet-
As @ICER_review places a spotlight on #pharma's #drugpricing hikes, J&J, Roche and more hit back https://t.co/qYSsuwzk5g
-
-
Mashup Score: 0
Democratic members of the Senate’s health committee will hold another hearing on an evergreen topic: drug pricing. | Democratic members of the Senate’s health committee will hold another hearing on an evergreen topic: drug pricing. The CEOs of Johnson & Johnson, Merck & Co. and Bristol Myers Squibb are invited to testify.
Source: www.fiercepharma.comCategories: General Medicine News, General HCPsTweet-
Democrats summon CEOs of J&J, Merck and BMS for Senate hearing on drug prices | #pharma #drugpricing https://t.co/TVP9vQzgkY
-
.@eNavvi Mark Cuban @CostPlusDrugs Company partner to empower physicians - Physicians will have the ability to compare medication prices in real-time and prescribe using eNavvi's platform | #pharma #drugpricing https://t.co/ypXxxRvglS